AskAt received a Notice of Allowance dated April 7, 2022 for a formulation patent for AAT-076, its COX-2 inhibitor. The Notice was issued by the China National Intellectual Property Administration (CNIPA) in connection with Chinese Patent Application No. 201910582831.7 (Filing Date: October 18, 2012). To date, in addition to China, the formulation patent has been granted in Canada, Europe, Japan, Korea, Mexico, Russia, and the U.S.